Summary
For women who carry the breast cancer 1 gene mutation. Finding out if removing just the fallopian tubes now and the ovaries later is as good as removing both the tubes and ovaries at the same time for lowering the risk of ovarian cancer in women who have a harmful BRCA1 gene mutation
Description
To compare the non-inferiority of bilateral salpingectomy (BLS) with delayed oophorectomy to bilateral salpingo-oophorectomy (BSO) to reduce the risk of ovarian cancer among women with deleterious BRCA1 germline mutations.
Principal Investigator
Stephen Bush
Study Coordinator
Lisa Luikart
Faculty Contact
Stephen Bush, DO
Research Contact
Lisa Luikart
CAMC Cancer Research Center
304.388.9944
lisa.luikart@vandaliahealth.org
Departments
Sex
Female
Age
35-50
IRB Number
20-707